Skip to content
The Nexus
DossierENTITY

bimagrumab

Coverage of bimagrumab in the Nexus archive.

Earliest in view: Jun 21 · 11:23 UTCMost recent: Jun 21 · 11:23 UTC
Co-mentioned in this coverage
Eli Lillyorganization1AstraZenecaorganization1Novo Nordiskorganization1Cambrian Biotechorganization1SPX-001topic1CagriSematopic1ATX-304topic1James Peyerperson1
Recent coverage
  • HEALTHJun 21 · 11:23 UTCBUSINESS INSIDER
    Weight loss without muscle loss? The next generation of drugs is testing the idea

    Pharmaceutical companies are developing drugs to preserve muscle mass during weight loss, addressing an issue with existing GLP-1 drugs like Ozempic. Candidates such as bimagrumab, SPX-001, and CagriSema aim to reduce fat while retaining lean mass, with Cambrian Biotech testing a drug that mimics exercise to boost metabolism.